Publication | Closed Access

Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma

HepatologyMedicinePharmacologyPathologySystemic Combination TherapyLiver CancerInterferon Alfa-2aCancer TreatmentLiver TransplantationOncologyRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma